Authors:
Banchereau, J
Palucka, AK
Dhodapkar, M
Burkeholder, S
Taquet, N
Rolland, A
Taquet, S
Coquery, S
Wittkowski, KM
Bhardwaj, N
Pineiro, L
Steinman, R
Fay, J
Citation: J. Banchereau et al., Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine, CANCER RES, 61(17), 2001, pp. 6451-6458
Authors:
Desikan, KR
Tricot, G
Dhodapkar, M
Fassas, A
Siegel, D
Vesole, DH
Jagannath, S
Singhal, S
Mehta, J
Spoon, D
Anaissie, E
Barlogie, B
Munshi, N
Citation: Kr. Desikan et al., Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone, BONE MAR TR, 25(5), 2000, pp. 483-487
Authors:
Singhal, S
Mehta, J
Desikan, R
Ayers, D
Roberson, P
Eddlemon, P
Munshi, N
Anaissie, E
Wilson, C
Dhodapkar, M
Zeldis, J
Barlogie, B
Siegel, D
Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
Authors:
Desikan, R
Dhodapkar, M
Siegel, D
Fassas, A
Singh, J
Singhal, S
Mehta, J
Vesole, D
Tricot, G
Jagannath, S
Anaissie, E
Barlogie, B
Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996